[1]
Serkan Yaraş, Enver Üçbilek, Osman Özdoğan, Fehmi Ateş, Engin Altıntaş, and Orhan Sezgin, “Real-life results of treatment with ombitasvir, paritaprevir, dasabuvir, and ritonavir combination in patients with chronic renal failure infected with HCV in Turkey”, Turkish Journal of Gastroenterology, vol. 30, no. 4, pp. 331–335, Jul. 2019.